Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$2.31M Buy
41,030
+891
+2% +$52.1K 0.86% 40
2016
Q3
$2.39M Hold
40,139
0.89% 40
2016
Q2
$2.21M Hold
40,139
0.89% 41
2016
Q1
$2.03M Buy
40,139
+7,179
+22% +$352K 0.81% 45
2015
Q4
$1.66M Sell
32,960
-1,042
-3% -$52.5K 0.66% 48
2015
Q3
$1.6M Sell
34,002
-6
-0% -$319 0.68% 47
2015
Q2
$1.85M Sell
34,008
-12,628
-27% -$708K 0.7% 46
2015
Q1
$2.56M Buy
46,636
+4,140
+10% +$234K 0.99% 36
2014
Q4
$2.3M Sell
42,496
-7,179
-14% -$400K 0.91% 41
2014
Q3
$2.81M Buy
49,675
+10,113
+26% +$568K 1.16% 32
2014
Q2
$2.18M Buy
39,562
+3,432
+9% +$187K 0.92% 42
2014
Q1
$1.96M Buy
36,130
+7,520
+26% +$389K 0.88% 47
2013
Q4
$1.37M Buy
+28,610
New +$1.31M 0.63% 57

Other funds holding MRK

CG Asset Management's MRK Position: Q4 2016 in Review

CG Asset Management increased its Merck (MRK) stake by 2.2% in Q4 2016, buying an estimated $52.1K and bringing the position to 41,030 shares worth $2.31M. The position accounts for 0.86% of the portfolio, ranked #40.

CG Asset Management first reported a position in MRK in Q4 2013 and has held it in 13 quarters since. The position peaked at $2.81M in Q3 2014. 1,912 funds tracked by Wall St. Rank hold MRK as of Q4 2016.

  • CG Asset Management held 41,030 shares of Merck worth $2.31M as of Q4 2016.
  • CG Asset Management bought 891 Merck shares in Q4 2016, an estimated $52.1K.
  • Merck made up 0.86% of CG Asset Management's portfolio in Q4 2016, its #40 holding.
  • CG Asset Management first reported a position in Merck in Q4 2013 and has held it in 13 quarters since.
  • CG Asset Management's Merck position peaked at $2.81M in Q3 2014.
  • 1,912 funds tracked by Wall St. Rank held Merck as of Q4 2016.

Based on CG Asset Management's 13F filing for Q4 2016, filed 10 Feb 2017.